| |
| | Biogen Announces European Distribution Agreements For Interferon Beta-1a With Astra And Schering-Plough |
 | | CAMBRIDGE, Mass., Aug. 8 /PRNewswire/ -- Biogen (Nasdaq: BGEN) today announced that it has signed two exclusive European distribution agreements for interferon beta-1a, which is marketed in the United States as AVONEX(TM), for the treatment of relapsing forms of multiple sclerosis. |
 | | Under an agreement with Astra AB of Sweden, at such time as the drug is approved, Astra will have rights to distribute, market and sell interferon beta-1a in the Nordic countries, which include Denmark, Finland, Iceland, Norway and Sweden. |
 | | Under an agreement with Schering-Plough S.A., Schering- Plough obtains rights to distribute interferon beta-1a in Spain at such time as it is approved. |
| www.prnewswire.com /cgi-bin/stories.pl?ACCT=105&STORY=/www/story/25309 (538 words) |
|